Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. Looking ahead to 2019, the pharmacy business is poised to be more disrupted than ever before. Over the past 10 years, our members have successfully navigated a number of headwinds to their operating and regulatory environments, including price compression, regulatory
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. For much of 2018, capital markets for biotech investment were strong. Some 53 biotech companies went public with more than $5.4 billion in funding, putting the biotech industry on track for the second-best year for IPOs in a decade. And
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. This past June, Secretary of Health and Human Services Alex Azar told the Senate Finance Committee, “We need a strong, robust generic market.” He followed this statement with an observation that resonated for many of the member companies of the
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. Pharmacists are medication experts. Every day, they get to see the remarkable difference innovative treatments can make in their customers’ lives. But like America’s biopharmaceutical companies, they also know those innovative medicines aren’t nearly as meaningful if they are too
CHICAGO — A new era has begun at IRI. Already a leading provider of big data, predictive analytics and insights that help clients grow their business, the company is now in an even better position to have an impact on the marketplace as a result of a new financial structure. Last month, IRI closed a
There has been significant focus and attention paid to the issue of drug prices in the last few years. As Adam Fein, president of Pembroke Consulting Inc. and chief executive officer of Drug Channels Institute, has said, “Drugs are 12% of the costs, but 90% of the conversation.” Fortunately, the spirited national conversation about drug
SEATTLE — Founded in 1890, Bartell Drugs has maintained a leading position in the greater Seattle market by staying close to local consumers and continually developing new ways of addressing their changing needs. “My grandfather instilled in us the value of customer service,” says George Bartell, chairman of the 68-store retailer. “Serving the customer is
DEERFIELD, Ill. — Walgreens is continuing to transform its retail business, and one of the principal architects of the transformation is senior vice president and chief merchandising officer Joe Hartsig. In recognition of his contribution, the editors of Chain Drug Review have named Hartsig its 2018 Merchant of the Year. Hartsig, who joined Walgreens in
Drug prices are a major target of patient groups and Congress, although drug spending makes up only 10% of the $3.3 trillion spent on U.S. health care in a year. The prices for certain specialty drugs, such as sole-source cancer and immune therapy treatments, has led to perceptions that drug prices are egregious and pose
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) recently announced three global leadership appointments. Vineet Mehra will be joining WBA as global chief marketing officer. He will be based at corporate headquarters here and will report to WBA co-chief operating officers Ornella Barra and Alex Gourlay. As global CMO, Mehra will be responsible for the visioning,
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) and Verily, an Alphabet company, will be collaborating on multiple projects under a broad agreement aimed at improving health outcomes for patients with chronic conditions, while also lowering the cost of care. Walgreens will be a first-choice retail pharmacy development and commercialization partner to Verily, and the organizations
NEW YORK — Robust sales from before Thanksgiving through Christmas gave retailers much to cheer about at the end of last year. Holiday sales increased 5.1% to more than $850 billion — the strongest growth in the past six years, according to Mastercard SpendingPulse. Online shopping saw a 19.1% advance over 2017, with Amazon reporting
Editor’s note: The fourth in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. By Todd Huseby and Carol Cruickshank Traditionally, the approach to health in the United States has been reactive or at best responsive. Patients visit their providers only when an issue arises; providers
The law of the land for almost a decade, the Patient Protection and Affordable Care Act of 2010 is as controversial now as it was when it was enacted. Republicans’ negative view of the legislation remains diametrically opposed to that of Democrats, public opinion is divided, and the courts continue to issue often contradictory rulings
